Foundation Healthcare Lists on SGX in S$1 Billion IPO
Built on three core verticals – Specialists, Medical Centres and Technology, $FoundationHealth(FHH.SI)$ is an integrated private healthcare platform that connects medical specialists, healthcare providers, payors, patients and facilities across the healthcare ecosystem in Singapore. FHH MU Pic 1 FHH is the largest multi-specialty healthcare platform based on number of specialists and specialist clinics among key private specialist groups in Singapore, according to Frost & Sullivan. It provides specialist medical services through its 108 Medical Specialists across 16 medical specialties and 74 specialist clinics as at 31 March 2026. FHH owns and operates four medical centres in Singapore, comprising two day surgery centres, a radi
Weekly: Aspial Lifestyle, NeraTel, Nam Cheong & LMS Compliance directors see Huge Acquisitions
While the index benchmarks consolidated, Director and CEO activity notched higher over the five sessions through to the 2 July close. Over the five sessions, more than 120 director interests and substantial shareholdings were filed for around 50 primary-listed stocks. 1. $Aspial Lifestyle(5UF.SI)$ Between 26 June and 30 June, Non-Executive Chairman Koh Wee Seng acquired a total of 1,331,200 shares via market transactions at an average price of S$0.354 per share for a combined consideration of S$471,245, increasing his direct interest to 9.95% from 9.88%. His total interest increased to 75.67% from 75.60%, while his deemed interest remained unchanged at 65.72%. 2. $NeraTel(N01.SI)$ Between 25 Jun
1H26 SMID Participation Growth Outpaced Share Price Gains The 240 Singapore small and mid-cap (SMID) stocks with market capitalisations ranging from S$100 million to S$10 billion as of 30 June generated a S$696 million average daily turnover (ADT) run rate in 1H26. SMIDs listed prior to the past 12 months accounted for S$663 million of average daily turnover, while the IPO and secondary fundraising cohort over the past 12 months contributed the balance from their respective listing and fundraising dates. Trading activity strengthened across three consecutive half-year periods. ADT for constituents already listed prior to the past 12 months increased from S$362 million in 1H25 to S$459 million in 2H25 and S$663 million in 1H26. The increase in trading activity exceeded the pace
SGX H2 2026 Outlook: Strong H1 Momentum Sets the Stage for a More Selective Second Half
The first half of 2026 has officially come to an end, and Singapore’s equity market entered the second half from a position of strength. As of the end of June, the $Straits Times Index(STI.SI)$ closed at 5,170.65, up 11.29% year to date. June also remained positive, with the index gaining 2.64% for the month. At first glance, this looks like a strong and steady market rally. But beneath the headline index, performance was much more uneven. Capital did not move across the whole market equally. Instead, investors concentrated on a few clear themes: banks, SGX, semiconductor equipment, industrial machinery, renewable electricity, China-linked ETFs, and selected REITs. The first half showed that Singapore’s market was not simply defe